NCT01081275

Brief Summary

This study will compare two different kinds of physical therapy to improve use of the hands in individuals with multiple sclerosis (MS). One treatment will be Constraint-Induced Movement therapy (CI therapy), the other will be a set of Complementary and Alternative Medicine (CAM) treatments (yoga, relaxation exercises, aquatherapy, massage). The study will determine which of the two forms of treatment is more successful for improving hand use.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for phase_2 multiple-sclerosis

Timeline
Completed

Started Feb 2010

Longer than P75 for phase_2 multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 5, 2010

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 15, 2015

Status Verified

April 1, 2015

Enrollment Period

6 years

First QC Date

March 4, 2010

Last Update Submit

April 14, 2015

Conditions

Keywords

Multiple SclerosisMSCI TherapyCIMTConstraint-Induced Movement TherapyComplementary and Alternative MedicineCAMPhysical TherapyOccupational TherapyRelaxationExerciseMassageYogaPool TherapyAquatherapyAquatic Therapy

Outcome Measures

Primary Outcomes (1)

  • Motor Activity Log (MAL)

    The MAL is a structured interview on the amount and quality of the more-affected hand use during daily living activities.

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

Secondary Outcomes (8)

  • Wolf Motor Function Test (WMFT)

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

  • MSFC (Multiple Sclerosis Composite Measure)

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

  • SARA (Scale for the Assessment and Rating of Ataxia)

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

  • EDSS (Expanded Disability Status Scale)

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

  • Fatigue Severity Scale (FSS)

    Before treatment, and immediately, 6 months, and 12 months after the end of treatment.

  • +3 more secondary outcomes

Study Arms (2)

CI Therapy

ACTIVE COMPARATOR

CI therapy involves repetitive practice with the more-affected hand on typical daily living activities (such as stacking objects, pouring, moving objects) for 3.5 hours per day, along with physical restraint of the better hand to keep it from assisting, and home practice exercises.

Behavioral: CI Therapy

CAM treatments

ACTIVE COMPARATOR

CAM treatments are holistic physical treatments designed to work on the entire body to improve quality of life and overall health. This study will use yoga, relaxation exercises, aquatherapy (pool therapy), and massage.

Behavioral: CAM treatments

Interventions

CI TherapyBEHAVIORAL

CI Therapy will be given for 3.5 hours per day, Monday-Friday, for 2 consecutive weeks.

Also known as: Constraint-Induced Movement therapy
CI Therapy
CAM treatmentsBEHAVIORAL

CAM treatments will be given for 3.5 hours per day, Monday-Friday, for 2 consecutive weeks.

Also known as: Complementary and Alternative Medicine
CAM treatments

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of non-relapsing multiple sclerosis (primary progressive MS, secondary progressive MS)
  • reduced use of one of the hands because of MS
  • ability to pick up and release a small object with the more-affected hand when requested
  • can travel to the treatment program at the University of Alabama at Birmingham (UAB)
  • can undergo treatment for 2 weeks (Monday-Friday), 3.5 hours per day
  • can undergo MRI scan
  • any kind of medication used for MS is allowed except spasticity medicine

You may not qualify if:

  • disease relapse in the past 3 months
  • pregnancy
  • marked pain with arm movement
  • severe uncontrolled medical illness
  • simultaneous treatment with another form of physical therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States

Location

Related Publications (3)

  • Mark VW, Taub E, Bashir K, Uswatte G, Delgado A, Bowman MH, Bryson CC, McKay S, Cutter GR. Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings. Mult Scler. 2008 Aug;14(7):992-4. doi: 10.1177/1352458508090223. Epub 2008 Jun 23.

    PMID: 18573826BACKGROUND
  • Barghi A, Allendorfer JB, Taub E, Womble B, Hicks JM, Uswatte G, Szaflarski JP, Mark VW. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity. Neurorehabil Neural Repair. 2018 Mar;32(3):233-241. doi: 10.1177/1545968317753073.

  • Mark VW, Taub E, Uswatte G, Morris DM, Cutter GR, Adams TL, Bowman MH, McKay S. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function. Neurorehabil Neural Repair. 2018 Mar;32(3):223-232. doi: 10.1177/1545968318761050.

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Interventions

Constraint Induced Movement TherapyComplementary Therapies

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Victor W Mark, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 4, 2010

First Posted

March 5, 2010

Study Start

February 1, 2010

Primary Completion

February 1, 2016

Study Completion

March 1, 2016

Last Updated

April 15, 2015

Record last verified: 2015-04

Locations